Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study

BACKGROUND: Major depressive disorder (MDD) constitutes the leading cause of disability worldwide. Although efficacious antidepressant pharmacotherapies exist for MDD, only about 40–60% of the patients respond to initial treatment. However, there is still a lack of robustly established and applicabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Agorastos, Agorastos, Sommer, Anne, Heinig, Alexandra, Wiedemann, Klaus, Demiralay, Cüneyt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251160/
https://www.ncbi.nlm.nih.gov/pubmed/32508691
http://dx.doi.org/10.3389/fpsyt.2020.00453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251160/
https://www.ncbi.nlm.nih.gov/pubmed/32508691
http://dx.doi.org/10.3389/fpsyt.2020.00453

Ejemplares similares